Relief of obstructive pelvic venous symptoms with endoluminal stenting

Blättler, W.; Blättler, Irene K.

doi:10.1016/s0741-5214(99)70277-6

Cited by 57 publications

(25 citation statements)

References 2 publications

(2 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Introduced in the 1990s for the treatment of vena cava stenoses, 43,44 endovenous stent therapy has emerged as an effective, minimally invasive discipline for restoring patency in chronic iliofemoral/caval vein obstruction caused by I-F DVT 7,8,[20][21][22]25,26,29,30 or the May-Thurner syndrome. 7,23-25,27-29 Performed under local anesthesia and intravenous analgesia 15,39 with a technical success of 90% or greater, and a midterm assisted patency exceeding 80% (Table 1), it facilitates the treatment of related venous complications (C3-C6), and improves the walking capacity of the afflicted individuals.…”

Section: Discussionmentioning

confidence: 99%

Successful Iliac Vein and Inferior Vena Cava Stenting Ameliorates Venous Claudication and Improves Venous Outflow, Calf Muscle Pump Function, and Clinical Status in Post-Thrombotic Syndrome

Delis¹,

Bjarnason²,

Wennberg³

et al. 2007

Annals of Surgery

100

View full text Add to dashboard Cite

Successful I-F (+/-IVC) stenting in limbs with venous outflow obstruction and complicated CVD (C3-C6) ameliorates venous claudication, normalizes outflow, and enhances calf muscle pump function, compounded by a significant clinical improvement of CVD. The significant increase in the amount of venous reflux of the stented limbs indicates that elastic or inelastic compression support of the successfully stented limbs would be pivotal in preventing disease progression.

show abstract

Section: Discussionmentioning

confidence: 99%

Successful Iliac Vein and Inferior Vena Cava Stenting Ameliorates Venous Claudication and Improves Venous Outflow, Calf Muscle Pump Function, and Clinical Status in Post-Thrombotic Syndrome

Delis¹,

Bjarnason²,

Wennberg³

et al. 2007

Annals of Surgery

100

View full text Add to dashboard Cite

show abstract

“…After screening 793 studies for eligibility, 37 studies reporting 45 treatment effects (nonthrombotic, [12][13][14][15][16][17][18][19] AT, 13,18,[20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36] and CPT 12,14,17,30,33,34,[37][38][39][40][41][42][43][44][45][46][47][48] ) from 2869 unique patients (nonthrombotic, 1122; AT, 629; and CPT, 1118) were included in the meta-analysis. The most common reasons for study exclusion were lack of relevant stent placement outcomes (19 studies), kin relationships (18 studies), sample size <10 (16 studies), combined outcome reporting in nonthrombotic and thrombotic patients (8 studies), and combined outcome reporting in AT and CPT patients (6 studies).…”

Section: Study Selectionmentioning

confidence: 99%

Safety and Effectiveness of Stent Placement for Iliofemoral Venous Outflow Obstruction

Razavi

Jaff

Miller

2015

Circ: Cardiovascular Interventions

224

117

View full text Add to dashboard Cite

Background-Endovenous recanalization of iliofemoral stenosis or occlusion with angioplasty and stent placement has been increasingly used to maintain long-term venous patency in patients with iliofemoral venous outflow obstruction. The purpose of this systematic review and meta-analysis was to determine safety and effectiveness of venous stent placement in patients with iliofemoral venous outflow obstruction. Methods and Results-We searched MEDLINE and EMBASE for studies evaluating safety or effectiveness of stent placement in patients with iliofemoral venous outflow obstruction. Data were extracted by disease pathogenesis: nonthrombotic, acute thrombotic, or chronic post-thrombotic. Main outcomes included technical success, periprocedural complications, symptom relief at final follow-up, and primary/secondary patency through 5 years. A total of 37 studies reporting 45 treatment effects (nonthrombotic, 8; acute thrombotic, 19; and chronic post-thrombotic, 18) from 2869 patients (nonthrombotic, 1122; acute thrombotic, 629; and chronic post-thrombotic, 1118) were included. Technical success rates were comparable among groups, ranging from 94% to 96%. Complication rates ranged from 0.3% to 1.1% among groups for major bleeding, from 0.2% to 0.9% for pulmonary embolism, from 0.1% to 0.7% for periprocedural mortality, and from 1.0% to 6.8% for early thrombosis. Patient symptom relief data were reported inconsistently. At 1 year, primary and secondary patency were 96% and 99% for nonthrombotic, 87% and 89% for acute thrombotic, and 79% and 94% for chronic post-thrombotic. Conclusions-Stent Methods Literature SearchThis study was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses. 9 We searched MEDLINE and EMBASE for randomized or nonrandomized controlled studies and prospective or retrospective case series of stent placement for treatment of iliofemoral venous outflow obstruction by using a combination of relevant keywords. The details of the MEDLINE search strategy are listed in Table I in the Data Supplement. The syntax for EMBASE was similar, but adapted as necessary. In addition, manual searches were conducted using the Directory of Open Access Journals, Google Scholar, and the reference lists of included papers and relevant meta-analyses. No date restrictions were applied to the searches. The final search was conducted March 15, 2015. Study SelectionTwo researchers independently selected studies for inclusion in the review. Disagreements were resolved by consensus. Titles and abstracts were initially screened to exclude review articles, commentaries, letters, case reports, and obviously irrelevant studies. Full texts of the remaining articles were retrieved and reviewed. Main inclusion criteria included studies with (1) primary diagnosis of obstructive lesions of the common femoral vein, external iliac vein, and the common iliac vein, (2) stent placement in the common femoral vein, external iliac vein, common iliac vein, and the inferior vena cava, (3) outcomes reporte...

show abstract

“…Korrektive Eingriffe am tiefen Venensystem werden zurzeit nur in spezialisierten Zentren durchgeführt und befinden sich vielfach noch im experimentellen Stadium. Als Verfahren mit nachgewiesener Effizienz kann die Implantation von Stents in die postthrombotisch verengte V. iliaca communis angesehen werden, wenn eine Kollateralisierung über das kleine Becken und die im Spinalkanal vorhandenen Venenplexus zu lumbalen oder radikulä-ren Symptomen,vor allem nach körperlicher Anstrengung,führt [15,16] -eine Symptomatik, die nicht selten von unerfahrenen Untersuchern übersehen wird. Ebenso erlauben diverse Valvuloplastieverfahren eine Wiederherstellung der Klappenfunktion bei primärer Leitveneninsuffizienz mit akzeptablen Erfolgsraten bei Ulkuspatienten [17].…”

Section: Defekte Am Tiefen Venensystemunclassified

Operative Ulkustherapie

2003

Hautarzt

View full text Add to dashboard Cite

Surgical treatment of venous leg ulcers is a domain of dermatology. Special knowledge of differential diagnosis considerations and various treatment options are necessary to develop complex, sometimes interdisciplinary treatment plans together with angiologists,vascular surgeons and interventional radiologists. Besides surgical treatment options aiming towards normalization of venous hemodynamics, local options such as shave or total ulcer excision are well established. Additionally, new surgical techniques such as subfascial endoscopic perforator surgery (SEPS) or implantation of iliac stents now have their place in the surgical treatment of venous ulcer disease.

show abstract

Relief of obstructive pelvic venous symptoms with endoluminal stenting

Abstract: Venous claudication and neurogenic claudication caused by venous collaterals in the spinal canal are typical clinical features of CPPVO. We recommend searching for these symptoms, because recanalization by means of stenting is often feasible and rewarding.

Cited by 57 publications

References 2 publications

Successful Iliac Vein and Inferior Vena Cava Stenting Ameliorates Venous Claudication and Improves Venous Outflow, Calf Muscle Pump Function, and Clinical Status in Post-Thrombotic Syndrome

Successful Iliac Vein and Inferior Vena Cava Stenting Ameliorates Venous Claudication and Improves Venous Outflow, Calf Muscle Pump Function, and Clinical Status in Post-Thrombotic Syndrome

Safety and Effectiveness of Stent Placement for Iliofemoral Venous Outflow Obstruction

Operative Ulkustherapie

Contact Info

Product

Resources

About